HYUNDAI BIOLAND Co.,Ltd. (KOSDAQ:052260)
South Korea · Delayed Price · Currency is KRW 4,130.00
+186.83 (4.74%)
At close: Apr 1, 2026
HYUNDAI BIOLAND Income Statement
Financials in millions KRW. Fiscal year is January - December.
Millions KRW. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Other Revenue | - | - | - | - | -0 |
| 130,505 | 119,519 | 96,720 | 99,154 | 102,802 | |
Revenue Growth (YoY) | 9.19% | 23.57% | -2.46% | -3.55% | 15.64% |
Cost of Revenue | 77,094 | 66,832 | 57,191 | 63,792 | 65,808 |
Gross Profit | 53,411 | 52,687 | 39,529 | 35,361 | 36,994 |
Selling, General & Admin | 31,386 | 27,174 | 18,640 | 17,044 | 16,680 |
Research & Development | 7,437 | 7,300 | 6,171 | 7,470 | 7,935 |
Amortization of Goodwill & Intangibles | 232.5 | 262.18 | 280.37 | 281.49 | 258.34 |
Other Operating Expenses | 503.09 | 572.19 | 243.6 | 445.67 | 417.52 |
Operating Expenses | 40,656 | 36,361 | 26,101 | 26,306 | 26,336 |
Operating Income | 12,755 | 16,326 | 13,428 | 9,055 | 10,658 |
Interest Expense | -470.08 | -501.55 | -550.69 | -1,277 | -1,334 |
Interest & Investment Income | 704.64 | 863.21 | 970.19 | 466.02 | 185.78 |
Currency Exchange Gain (Loss) | 27.13 | 2,229 | 296.32 | 291.18 | 590.04 |
Other Non Operating Income (Expenses) | -684.62 | -224.31 | 94.95 | 4.23 | 92.74 |
EBT Excluding Unusual Items | 12,332 | 18,693 | 14,239 | 8,540 | 10,192 |
Gain (Loss) on Sale of Investments | -62.01 | 50.81 | -461.97 | -186.82 | -306.29 |
Gain (Loss) on Sale of Assets | 78.51 | 14.46 | 2,154 | 144.09 | -772.91 |
Asset Writedown | - | -2,874 | 1,515 | -1,653 | -24,278 |
Pretax Income | 12,349 | 15,884 | 17,446 | 6,844 | -15,165 |
Income Tax Expense | 817.77 | 3,573 | 3,601 | 2,080 | -3,479 |
Earnings From Continuing Operations | 11,531 | 12,311 | 13,845 | 4,764 | -11,686 |
Earnings From Discontinued Operations | -11,278 | -6,607 | -5,788 | - | - |
Net Income | 252.62 | 5,703 | 8,056 | 4,764 | -11,686 |
Net Income to Common | 252.62 | 5,703 | 8,056 | 4,764 | -11,686 |
Net Income Growth | -95.57% | -29.21% | 69.09% | - | - |
Shares Outstanding (Basic) | 30 | 30 | 30 | 30 | 30 |
Shares Outstanding (Diluted) | 30 | 30 | 30 | 30 | 30 |
EPS (Basic) | 8.42 | 190.10 | 268.54 | 158.81 | -389.54 |
EPS (Diluted) | 8.42 | 190.10 | 268.54 | 158.81 | -389.54 |
EPS Growth | -95.57% | -29.21% | 69.09% | - | - |
Free Cash Flow | 15,480 | 957.38 | -179.4 | 7,530 | 19,215 |
Free Cash Flow Per Share | 515.99 | 31.91 | -5.98 | 250.99 | 640.48 |
Gross Margin | 40.93% | 44.08% | 40.87% | 35.66% | 35.98% |
Operating Margin | 9.77% | 13.66% | 13.88% | 9.13% | 10.37% |
Profit Margin | 0.19% | 4.77% | 8.33% | 4.81% | -11.37% |
Free Cash Flow Margin | 11.86% | 0.80% | -0.18% | 7.59% | 18.69% |
EBITDA | 17,635 | 22,845 | 19,728 | 15,383 | 19,219 |
EBITDA Margin | 13.51% | 19.11% | 20.40% | 15.51% | 18.70% |
D&A For EBITDA | 4,880 | 6,518 | 6,301 | 6,328 | 8,561 |
EBIT | 12,755 | 16,326 | 13,428 | 9,055 | 10,658 |
EBIT Margin | 9.77% | 13.66% | 13.88% | 9.13% | 10.37% |
Effective Tax Rate | 6.62% | 22.50% | 20.64% | 30.39% | - |
Advertising Expenses | 5,222 | 2,802 | 222.68 | 321.77 | 502.01 |
Updated Dec 31, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.